跳至主要内容
临床试验/PACTR202010690466874
PACTR202010690466874尚未招募2 期

Repurposing the aqueous extract of cryptolepis for COVID-19 immunotherapy

Kwame Nkrumah University of Science and Technology0 个研究点目标入组 20 人开始时间: 2020年10月1日最近更新:
适应症

试验速览

阶段
2 期
状态
尚未招募
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
19 Year(s) 至 44 Year(s)(—)
性别
All

入选标准

  • Provision of signed and dated informed consent form.
  • Stated willingness to comply with all study procedures and availability for the duration of the study.
  • Male or female, aged 18 or above.
  • Covid-19 laboratory confirmed.
  • Ability to take oral medication and be willing to adhere to the study inter-vention regimen.

排除标准

  • Presence of Pregnancy or lactation.
  • Known allergic reactions to components of the study intervention (C. san-guinolenta).
  • Treatment with another investigational drug other than the current Covid-19 standard therapy.
  • Treatment with herbal medicine in the past 4 weeks.
  • Current smoker.
  • Mentally unstable

研究者

相似试验